EW
Edwards Lifesciences Soars Past Expectations with 12.5% Second Quarter Sales Growth
Edwards Lifesciences, a leading global medical technology company, has delivered a stunning second quarter performance, exceeding expectations with a robust sales growth of 12.5%. The impressive results announced by the company on July 23rd have sent shockwaves in the healthcare sector, solidifying Edwards' position as a pioneer in